reference/5447503

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5447503

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	193
issn	0340-5761 1432-0738
issueIdentifier	1
pageRange	177-193
publicationName	Archives of Toxicology
startingPage	177
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b8b839d624da6ad1b5e43b42bd324953 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_463734b7f4e40dd63dcbc376179ba54f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_27587160a44a8f1e60ecafb58329b017 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06dba9892f7177bad16a05dc12bfd777 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_24c5a587eecc88653069dc60e809deeb
bibliographicCitation	Wachholz V, Mustafa AM, Zeyn Y, Henninger SJ, Beyer M, Dzulko M, Piée-Staffa A, Brachetti C, Haehnel PS, Sellmer A, Mahboobi S, Kindler T, Brenner W, Nikolova T, Krämer OH. Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3. Archives of Toxicology. 2021 Oct 19;96(1):177–93. doi: 10.1007/s00204-021-03174-1.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e40cd357d5f5e5054aac97222dc2911 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2501-8149 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4453-2573 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0f72448b4b0f0ce48079200e5a8d59b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8ddb11f89607afb8892c6649f00ebf2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3973-045X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1511-6212 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0958d9eb309fb0510e43b7edcb119677 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e596413a50f8677f6bc8ebbca0581308 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1a04079197e066ae382258266c480f18 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f81673df684b813df81c96f9f4bdee4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea838a61c61e7203d7f8392f36d36240 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6be83994fbae67acd519ef1d8491353 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7f6ba3a8eaeca1bc82bb88470e19b70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b877c000cea8decca33ff9d7885074d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4b886243337cb3425df2172fd5c5eea
date	2021-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8748367 https://pubmed.ncbi.nlm.nih.gov/34665271 https://doi.org/10.1007/s00204-021-03174-1
isPartOf	https://portal.issn.org/resource/ISSN/1432-0738 https://portal.issn.org/resource/ISSN/0340-5761 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/848
language	English
source	https://www.crossref.org/ https://scigraph.springernature.com/ https://pubmed.ncbi.nlm.nih.gov/
title	Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
discusses	http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0468902 http://id.nlm.nih.gov/mesh/M0224308 http://id.nlm.nih.gov/mesh/M0010420 http://id.nlm.nih.gov/mesh/M0190176
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID56650312 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f1b2452da84551fc91db93425b6a20d9 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1e18f7111f0fdc1484ceb2d0d4cb18ce http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24889392 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_582d5f2f504253c89e3a8210d6134600 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8077 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75be19437755fc2af3f5756d6bb1d737 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c343e6a7c6ed1f53a79a52a5af338d66 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e64b5f8a4c9c61082b4d0780664c293f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_34764464ee0281fcec2ec97a8b045de2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_848ea8bb1121ee393ad72ae0d412d8d2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45bd205c63f9c9cfc7d5ba167cb355f0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.5.1.98 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3c1afdc4df89db197401645db6998055 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf99a94c673fe4e93461af6be7e99f9e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5352062 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_136c69e09d851b028638b720528c4fdf http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.1.1.45 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_24fcc8ae2c4a3fc4fe2b5ecda59a20f4

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID196409687 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788084 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461500550 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID461500545 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53788098

Total number of triples: 78.